Morphine Modulation of The Brain's Pain Matrix (Mor2010)
|ClinicalTrials.gov Identifier: NCT01245244|
Recruitment Status : Completed
First Posted : November 22, 2010
Last Update Posted : September 21, 2012
The aim of the current project is to use a model of painful stimulation of skin, muscles and internal organs, where it is possible to measure activity in the brain centers that process pain simultaneously. Magnetic resonance imaging and electroencephalography are combined to optimize the anatomical and physiological description of brain activation. During administration of morphine we will identify how different brain areas are affected. This knowledge will be used to:
1. Understand the mechanisms of morphine to a greater extent than is possible today, including:
- to investigate the mechanisms of morphine versus placebo on pain signals in the spinal cord and brain. This is done by a combination of experimental pain models, neurophysiological and imaging techniques (EEG and fMRI). This can be achieved as both subjective and objective measures of the analgesic effect.
- to examine morphines effect on communication between the centers of the brain that are involved in painprocessing .
- modeling of morphine pharmacokinetics (the understanding of what the body does to the drug, such as. concentration in the blood and the brain), since this is central to understand the pharmacodynamics (the description of what the drug does to the body and thus the effect it has).
- to identify biomarkers that can predict whether healthy subjects respond to morphine by experiencing an analgesic effect.
|Condition or disease||Intervention/treatment||Phase|
|Pain||Drug: Morphine Other: orange juice||Phase 4|
The tests will consist of one main study (I) and one sub-study (i):
I) Experiments in the painlaboratory in the gastroenterology clinic, where 40 healthy subjects will be examined with different pain tests i) Experiments in the MRI scanner, where only 20 of the 40 from the main study will be investigated in a more simple pain model. The individuals who also participate in MRI studies, will consist of those who first sign up
An equal distribution of men and women is wanted. The trial will be a double-blind, placebo-controlled crossover study in which all subjects will be investigated on two seperate days and receive respectively placebo or morphine in random order
Skin will be stimulated with thermal and electrical stimuli. Stimulated by:
- Thermal stimuli by the skin stimulated with heat with an approved termotester (Medoc termotest) or with cold, by a hand or foot immersed in ice water. This harmless ice water test is further possible to evaluate DNIC (diffuse noxious Inhibitory controls) which is part of the pain system descending inhibitory system.
- Electrical stimulation of the skin will be done by: 1) to the skin of the forearm stimulated electrically through two small surface electrodes (each approx. One cm2). There are stimulated to pain threshold, 2) via surface electrodes placed under the foot. This activates the nociceptive avert reflex as recorded by electrodes placed on the leg.
The muscles can be stimulated by:
• mechanical stimuli by pressing the muscle with an approved pressure algometer (Somedic produktion AB, Sweden). There is an upper limit for the pressure to avoid injury.
Bone associated pain can be studied by:
• mechanical stimuli by pressing the right shin bone 15cm below the patella, medial of the tibia. Pressed with a handheld trykalgometer (Type 2, Somedic produktion AB, Sweden) with a probe size of 2mm in diameter until trial participants reach their pain tolerance threshold.
Visceral stimuli Stimuli to the rectum will be performed through the probe specifically designed for this purpose.
- mechanical stimuli will be applied by water filling a balloon which is glued on the probe. The balloon on the probe is extended to moderate pain. The expansion is done by slowly filling the balloon with 37 degrees hot water.
- Thermal stimuli will be applied by flushing the balloon with hot water (60 ° C)
- Electrical stimuli will be applied by stimulation of the mucosa with weak electrical currents (Less than 80 mA) through electrodes on the probe. This stimulus is also used for recording of evoked brain potentials.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Primary Purpose:||Basic Science|
|Official Title:||Morphine Modulation of The Brain's Pain Matrix|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||September 2012|
|Actual Study Completion Date :||September 2012|
Morphine oral mixture
Other Name: Morphine hydrochloride oral solution 2 mg/ml
|Placebo Comparator: Placebo||
Other: orange juice
Other Name: orange juice solution
- Morphine modulation of composite pain assessments [ Time Frame: october 2010 - december 2012 ]
- Side effects of morphine [ Time Frame: october 2010 - december 2012 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01245244
|Department of Gastroenterology, Aalborg Hospital|
|Aalborg, Denmark, 9000|
|Study Chair:||Anne E Olesen, PhD||Aalborg Universitetshospital|